Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.
about
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidenceTP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future researchIncidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan.Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinomaLow grade serious carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a "low-grade serous tubal intra-epithelial carcinoma" (STIC) on risk reducing surgery.Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.Expression of Cell Competition Markers at the Interface between p53 Signature and Normal Epithelium in the Human Fallopian Tube.Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinomaThe diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma.It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma.Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.BRCA and Early Events in the Development of Serous Ovarian Cancer.Pathogenesis and heterogeneity of ovarian cancer.Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum).Molecular-targeted therapies for ovarian cancer: prospects for the future.Hereditary gynaecological malignancies: advances in screening and treatment.Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.Biomarkers for early detection of ovarian cancer.Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.High-grade serous carcinoma of tubo-ovarian origin: recent developments.The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer.Tubal origin of ovarian cancer - the double-edged sword of haemoglobin.LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis.Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma.Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma.Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma.Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries.CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma.Who is at risk after risk reduction?Precancerous Lesions of Ovarian Cancer-A US Perspective.Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship.
P2860
Q26852127-3B6772BC-28E1-4674-BFAE-FD03AE9888F3Q30235845-E80220D1-227A-4A7D-9CD2-EDBB516701C1Q30250107-F24C1B21-30EB-4C0A-8CC9-9FFD315C5288Q34223292-F69764E6-497A-44CF-945C-AE3C3F872B99Q34543315-9B843612-3E1B-48E1-A40C-88A600A6A8A5Q34743857-24469774-3BFB-4678-8E8F-89CC6E1B3649Q35132433-4D5576DB-F41C-434D-BE55-7CF30AF8758EQ35642063-4C66AD30-7896-44D9-BDCF-43E2845A6BF6Q36004053-0FD42C67-633C-4A5B-9D6D-1B214CB975C7Q36039749-F46B75E6-7A7D-4E55-88FB-CEBCE739D34BQ36103306-6B97422B-EE50-4864-8D15-58389D31719EQ36405881-E5746313-CCF8-4D3B-B165-1C9E01E0E634Q36436803-B381B0BB-BA53-4BAA-BD5E-DE041779F56DQ37023858-A33FE720-3CB4-4736-A1AB-36413D1933FCQ37388203-EC4F0CC9-A839-4559-8D50-8D4128F3F179Q37513137-6298008C-35AF-43C7-ACA1-F0A9B13DA4CEQ37546692-B32E1054-56ED-4397-A80E-50662A051C0BQ37676705-60E1BC51-EE30-41A2-8AED-8E4297824E62Q37988903-13122E11-A516-43C8-87C6-93A47EA09059Q38036942-ABAC2434-2CB9-4A21-A14D-7FE74BB9ADA1Q38067433-4F9E4FD9-4DA9-44E3-BB8E-41BD97BAD63FQ38067435-E90054DB-4EF1-4303-8916-4A1E1D44D6A9Q38087982-52875803-BA9B-41A7-B858-01CB86CA97B4Q38198705-693620C0-4192-435E-8969-6F8B498C69A2Q38687061-DE28575D-288D-41E2-A2F9-0963D3568293Q38787667-3630C40F-7BF3-4783-9152-226DC1A84A6AQ38912872-C1F1ACDC-77E5-4910-93AC-BEABAD85E24CQ39068123-E6B268BF-FB4C-4EA5-AA3F-B2B321727DFAQ40140028-3D40BF3E-FF60-4237-9AAF-DDD5173DFF8BQ41179162-039B3158-60E1-429C-BDDE-8559D50A7772Q41291592-A79987BD-9657-480D-8885-77A51DA156E2Q42379619-22DF2E78-6679-42A7-A2E6-65EE0C00495BQ44568047-D3157BD0-8779-4464-9BEB-8E2A7943AEE0Q47189965-E04DEB81-FA37-48D5-ADE3-2896A05E7AA5Q47243819-68310EF6-EBFD-4C3F-A3CB-9836462C2359Q48148897-77B8722D-6C29-4528-98FC-7B267397A342Q48283598-F1F551F9-5BD1-4820-B141-C8AB7B839EC2Q49557150-2EF649F6-DE84-4D09-BE7D-598C9452525CQ50209189-17DD596D-C368-486A-89CF-D7E18DB14738Q53126713-04E3C817-FC10-4D5F-9E44-70B7C3B85AAE
P2860
Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Diagnosis of serous tubal intr ...... res: a reproducibility study.
@ast
Diagnosis of serous tubal intr ...... res: a reproducibility study.
@en
type
label
Diagnosis of serous tubal intr ...... res: a reproducibility study.
@ast
Diagnosis of serous tubal intr ...... res: a reproducibility study.
@en
prefLabel
Diagnosis of serous tubal intr ...... res: a reproducibility study.
@ast
Diagnosis of serous tubal intr ...... res: a reproducibility study.
@en
P2093
P2860
P1476
Diagnosis of serous tubal intr ...... ures: a reproducibility study
@en
P2093
Ie-Ming Shih
Kala Visvanathan
Patricia Shaw
Robert J Kurman
Russell Vang
Vinita Parkash
P2860
P304
P356
10.1097/PAS.0B013E31822F58BC
P407
P577
2011-12-01T00:00:00Z